Accelerated Approval Of Gene-Silencing Drug Now In Doubt.

Reuters (9/27, Joseph, Maddipatla) reports Alnylam Pharmaceuticals Inc. announced Thursday that it may delay plans to seek accelerated FDA approval for its gene-silencing drug givosiran until after full data from its trial comes out early next year. The...